For each retrieved tumor sample of xenograft, protein expression was evaluated using immunohistochemistry (IHC) with a monoclonal anti-PCNA antibody, CD31 to validate tumor growth inhibition and angiogenesis with 5-FU and shRRAD in xenografts (Fig. 4B). This evidence concerns the gene PECAM1 and neoplasm.